CLRB vs GME · $20.8M cap vs P/E 16, rev $3.63B
Cellectar Biosciences Inc (CLRB) versus GameStop Corp. (GME) — a side-by-side from cached financials, not a winner call.
Cellectar Biosciences Inc (CLRB) is a biotechnology company listed on US.
GameStop Corp. (GME) is a specialty retail company listed on US. It is led by Ryan Cohen.
CLRB does not have a complete income-statement cache yet.
Latest reported GME revenue for 2026-01-31 was $3.63B. Net income was $418.4M. Revenue was down 5.1% from 2025-02-01 to 2026-01-31. GME currently screens at market cap $9.78B and trailing P/E 16.3.
CLRB currently screens at market cap $20.8M. GME currently screens at market cap $9.78B and trailing P/E 16.3.
Not investment advice. Open the CLRB and GME stock pages for the full models.
Not investment advice.